Literature DB >> 7617183

Large hemispheric infarction, deterioration, and intracranial pressure.

J I Frank1.   

Abstract

Neurologic deterioration from large hemispheric infarction with edema (LHIE) often leads to the use of therapies directed at decreasing intracranial pressure (ICP). Many of these ICP therapies can potentially accentuate tissue shifts from unilateral mass lesions and lead to rebound ICP elevations. We sought to determine whether ICP elevation is a common cause of deterioration from LHIE by measuring the initial ICP and cerebral perfusion pressure (CPP) in 19 patients deteriorating to stupor from LHIE within 3 hours of deterioration, after ruling out metabolic aberrations, medication side effects, infection, and seizures and prior to commencement of any ICP-lowering therapies. We evaluated 19 patients aged 23 to 77 years--14 with complete middle cerebral artery and five with complete internal carotid artery territory infarctions. Stupor began 59 +/- 37 hours after the stroke onset. ICP monitoring (12 ipsilateral Camino, five contralateral ventriculostomy, and two ipsilateral epidural) demonstrated elevation of ICP (> 15 mm Hg) in only five patients (26.3%), with group mean initial ICP = 13.4 +/- 10 mm Hg. Similarly, the initial CPP was diminished (< 55 mm Hg) in only two patients (10.5%), with group mean initial CPP = 74.9 +/- 14 mm Hg. Globally elevated ICP is not a common cause of initial neurologic deterioration from LHIE mass effect.

Entities:  

Mesh:

Year:  1995        PMID: 7617183     DOI: 10.1212/wnl.45.7.1286

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  65 in total

Review 1.  Critical care of acute ischemic stroke.

Authors:  R A Bernstein; J C Hemphill
Journal:  Curr Neurol Neurosci Rep       Date:  2001-11       Impact factor: 5.081

2.  Emergency and critical care management of acute ischaemic stroke.

Authors:  Stephen A Figueroa; Weidan Zhao; Venkatesh Aiyagari
Journal:  CNS Drugs       Date:  2015-01       Impact factor: 5.749

3.  Mass Effect with Cerebral Infarction.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-07       Impact factor: 3.598

4.  Multimodal reperfusion therapy for large hemispheric infarcts in octogenarians: is good outcome a realistic goal?

Authors:  D Arkadir; R Eichel; J M Gomori; T Ben Hur; J E Cohen; R R Leker
Journal:  AJNR Am J Neuroradiol       Date:  2012-02-02       Impact factor: 3.825

5.  Managing malignant cerebral infarction.

Authors:  J Marc Simard; Juan Sahuquillo; Kevin N Sheth; Kristopher T Kahle; Brian P Walcott
Journal:  Curr Treat Options Neurol       Date:  2011-04       Impact factor: 3.598

6.  Hemicraniectomy for malignant middle cerebral artery infarction: retrospective consent to decompressive surgery depends on functional long-term outcome.

Authors:  Ines C Kiphuth; Martin Köhrmann; Christoph Lichy; Stefan Schwab; Hagen B Huttner
Journal:  Neurocrit Care       Date:  2010-12       Impact factor: 3.210

Review 7.  Osmotic therapy: fact and fiction.

Authors:  Michael N Diringer; Allyson R Zazulia
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

8.  Immune cell infiltration in malignant middle cerebral artery infarction: comparison with transient cerebral ischemia.

Authors:  Hannah X Chu; Hyun Ah Kim; Seyoung Lee; Jeffrey P Moore; Christopher T Chan; Antony Vinh; Mathias Gelderblom; Thiruma V Arumugam; Brad R S Broughton; Grant R Drummond; Christopher G Sobey
Journal:  J Cereb Blood Flow Metab       Date:  2013-12-11       Impact factor: 6.200

Review 9.  Drug treatment of acute ischemic stroke.

Authors:  Sameer Bansal; Kiranpal S Sangha; Pooja Khatri
Journal:  Am J Cardiovasc Drugs       Date:  2013-02       Impact factor: 3.571

10.  Bilateral near infrared spectroscopy in space-occupying middle cerebral artery stroke.

Authors:  M S Damian; R Schlosser
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.